Ownership
Private
Employees
~320
Therapeutic Areas
Gastroenterology
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Alimentiv General Information

Alimentiv (formerly Robarts Clinical Trials) specializes in global gastrointestinal clinical research. It has established itself as an industry leader in the design and execution of studies in inflammatory bowel disease and related GI conditions. The company collaborates with major pharmaceutical companies worldwide and academic institutions to deliver innovative trial designs, central imaging solutions, and precision medicine approaches.

Contact Information

Primary Industry
Contract Research Organization
Corporate Office
London, Ontario
Canada

Drug Pipeline

No pipeline data available

For full access to Alimentiv's pipeline data

Book a demo

Key Partnerships

Collaborates with six of the world’s ten largest pharmaceutical companies; works with over 1,200 hospitals/clinics globally. Specific partners are confidential.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Alimentiv Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Alimentiv's complete valuation and funding history, request access »

Alimentiv Financial Metrics